SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-007743
Filing Date
2020-06-24
Accepted
2020-06-24 17:00:27
Documents
2
Period of Report
2020-06-23
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20200623x8k.htm 8-K 30604
2 EX-3.1 tmb-20200623xex3d1.htm EX-3.1 153777
  Complete submission text file 0001558370-20-007743.txt   185525
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 20986281
SIC: 2834 Pharmaceutical Preparations